UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Journal of clinical oncology, ISSN 0732-183X, 12/2008, Volume 26, Issue 35, pp. 5775 - 5782
Life Sciences & Biomedicine | Oncology | Science & Technology | Immunopathology | Biological and medical sciences | Immunoglobulinopathies | Medical sciences | Immunodeficiencies. Immunoglobulinopathies | Tumors | Prospective Studies | Multiple Myeloma - mortality | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Transplantation, Autologous | Treatment Outcome | Remission Induction | Spain | Stem Cell Transplantation | Disease-Free Survival | Multiple Myeloma - therapy | Time Factors | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adult | Female | Aged | Transplantation Conditioning | Index Medicus
Journal Article
Leukemia, ISSN 0887-6924, 2020, Volume 34, Issue 11, pp. 2925 - 2933
Oncology | Life Sciences & Biomedicine | Hematology | Science & Technology | Chemotherapy | Genetic aspects | Transferases | Genetic polymorphisms | Cancer | Myeloid leukemia | Leukemia | Multivariate analysis | Risk analysis | Gene polymorphism | Patients | Subgroups | Risk factors | Genotype & phenotype | Cytarabine | Cytogenetics | Acute myeloid leukemia | Neutropenia | Index Medicus
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 09/2009, Volume 27, Issue 27, pp. 4578 - 4584
Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Tumors | Cyclophosphamide - administration & dosage | Antibodies, Monoclonal, Murine-Derived | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Mitoxantrone - administration & dosage | Humans | Middle Aged | Male | Vidarabine - analogs & derivatives | Antibodies, Monoclonal - administration & dosage | Adult | Female | Aged | Vidarabine - administration & dosage | Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy | Index Medicus
Journal Article
Journal of neuro-oncology, ISSN 0167-594X, 08/2020, Volume 149, Issue 1, pp. 13 - 25
Oncology | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Immunohistochemistry | Flow cytometry | Animal models | Bioluminescence | Cell survival | Immune response | PD-1 protein | Immunomodulation | Central nervous system | Parenchyma | Cytotoxicity | Inflammation | B-cell receptor | Macrophages | Patients | Lymphoma | Nuclear transport | Blood-brain barrier | Lymphocytes B | Xenografts | Movement disorders | B-cell lymphoma | Index Medicus | Laboratory Investigation | BTK | PCNSL | Innate immune system | XPO1
Journal Article
Blood, ISSN 0006-4971, 05/2011, Volume 117, Issue 18, pp. 4836 - 4843
Life Sciences & Biomedicine | Hematology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Immunohistochemistry | Prognosis | Oligonucleotide Array Sequence Analysis | Humans | Middle Aged | Kaplan-Meier Estimate | Rituximab | Immunophenotyping | Male | Antineoplastic Agents - therapeutic use | Gene Expression Profiling | Young Adult | Disease-Free Survival | Lymphoma, Large B-Cell, Diffuse - therapy | Algorithms | Immunotherapy | Adolescent | Aged, 80 and over | Lymphoma, Large B-Cell, Diffuse - immunology | Adult | Female | Aged | Lymphoma, Large B-Cell, Diffuse - genetics | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Index Medicus | Abridged Index Medicus
Journal Article
Genes chromosomes & cancer, ISSN 1045-2257, 11/2017, Volume 56, Issue 11, pp. 810 - 820
Oncology | Genetics & Heredity | Life Sciences & Biomedicine | Science & Technology | Gene Duplication | Recurrence | Proto-Oncogene Proteins c-ets - genetics | Humans | Middle Aged | PAX5 Transcription Factor - genetics | Leukemia, B-Cell - pathology | Repressor Proteins - genetics | Male | Histone Demethylases - genetics | Tumor Suppressor Protein p53 - genetics | DNA Copy Number Variations | Ikaros Transcription Factor - genetics | Antigens, Nuclear - genetics | Cyclin-Dependent Kinase Inhibitor p18 - genetics | Leukemia, B-Cell - genetics | Cyclin-Dependent Kinase Inhibitor p15 - genetics | Adult | Female | Ataxia Telangiectasia Mutated Proteins - genetics | Nuclear Proteins - genetics | Medical research | Analysis | Stem cells | Medicine, Experimental | Development and progression | Acute lymphocytic leukemia | Drug resistance | Tumor proteins | Cell proliferation | Multiplexing | Deregulation | Copy number | Leukemia | p53 Protein | Genes | Homeostasis | Single-nucleotide polymorphism | Pax5 protein | Alterations | Salvage | Pathways | Reproduction (copying) | Peripheral blood | Bone marrow | Evolution | Lesions | Acute lymphatic leukemia | Lymphatic leukemia | Gene expression | Patients | Lymphocytes B | Diagnostic systems | Index Medicus
Journal Article
Genes chromosomes & cancer, ISSN 1045-2257, 11/2019, Volume 58, Issue 11, pp. 815 - 819
Oncology | Genetics & Heredity | Life Sciences & Biomedicine | Science & Technology | Recurrence | Prognosis | Humans | Cyclin-Dependent Kinase Inhibitor p16 - genetics | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | Male | Biomarkers, Tumor | Disease Progression | Ikaros Transcription Factor - genetics | Neoplasm, Residual | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | Precursor Cell Lymphoblastic Leukemia-Lymphoma - metabolism | Cyclin-Dependent Kinase Inhibitor p15 - genetics | Gene Deletion | Adolescent | Cyclin-Dependent Kinase Inhibitor p16 - metabolism | Adult | Female | Cyclin-Dependent Kinase Inhibitor p15 - metabolism | Ikaros Transcription Factor - metabolism | Philadelphia Chromosome | Relapse | Transplantation | Genetic aspects | Adults | Acute lymphocytic leukemia | Hematopoietic stem cells | Diseases | Cancer | Profiling | Acute lymphatic leukemia | Leukemia | Health risks | Minimal residual disease | Stem cell transplantation | Lymphatic leukemia | Hemopoiesis | Philadelphia chromosome | Lymphocytes B | Risk assessment | Stem cells | Adolescents | Chromosomes | Index Medicus
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 2014, Volume 32, Issue 15, pp. 1595 - 1604
Life Sciences & Biomedicine | Oncology | Science & Technology | Multivariate Analysis | Predictive Value of Tests | Age Factors | Humans | Middle Aged | Male | Precursor Cell Lymphoblastic Leukemia-Lymphoma - mortality | Patient Selection | Neoplasm, Residual | Young Adult | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Flow Cytometry | Time Factors | Adult | Female | Maintenance Chemotherapy | Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology | Philadelphia Chromosome | Genetic Predisposition to Disease | Consolidation Chemotherapy - mortality | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Hematopoietic Stem Cell Transplantation | Logistic Models | Treatment Outcome | Spain | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | Disease-Free Survival | Phenotype | Adolescent | Consolidation Chemotherapy - adverse effects | Index Medicus
Journal Article
Clinical cancer research, ISSN 1078-0432, 01/2008, Volume 14, Issue 1, pp. 155 - 161
ZAP-70 | FCM | genes | Phase I-III Clinical Trials | Chronic Lymphocytic leukemia | Minimal residual disease | IgV | Leukemias and lymphomas | Hematologic, other | Life Sciences & Biomedicine | Oncology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Antineoplastic agents | Pharmacology. Drug treatments | Neoplasm, Residual - pathology | Cyclophosphamide - administration & dosage | Neoplasm, Residual - metabolism | Mitoxantrone - administration & dosage | Humans | Middle Aged | ZAP-70 Protein-Tyrosine Kinase - biosynthesis | Male | Cyclophosphamide - adverse effects | Female | Mitoxantrone - adverse effects | Vidarabine - adverse effects | Kaplan-Meier Estimate | Treatment Outcome | Vidarabine - analogs & derivatives | Remission Induction | Leukemia, Lymphocytic, Chronic, B-Cell - pathology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | L-Lactate Dehydrogenase - blood | ADP-ribosyl Cyclase 1 - biosynthesis | Leukemia, Lymphocytic, Chronic, B-Cell - metabolism | Neoplasm, Residual - drug therapy | Survival Analysis | Immunoglobulin Variable Region - genetics | Vidarabine - administration & dosage | Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy | Immunoglobulin Heavy Chains - genetics | Index Medicus
Journal Article
British journal of haematology, ISSN 0007-1048, 07/2019, Volume 186, Issue 2, pp. 263 - 268
hypodiploidy | prognosis | acute lymphoblastic leukaemia | age | adults | Life Sciences & Biomedicine | Hematology | Science & Technology | Age Factors | Humans | Middle Aged | Male | Survival Rate | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - therapy | Incidence | Neoplasm, Residual | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - genetics | Disease-Free Survival | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - mortality | Ploidies | Adolescent | Adult | Female | Aged | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - blood | Retrospective Studies | Aged patients | Prognosis | Acute lymphatic leukemia | Lymphocytes B | Hypodiploidy | Precursors | Leukemia | Medical prognosis | Older people | Minimal residual disease | Adults | Geriatrics | Index Medicus
Journal Article
European journal of haematology, ISSN 0902-4441, 05/2019, Volume 102, Issue 5, pp. 389 - 394
plasmacytomas | multiple myeloma | pomalidomide | Life Sciences & Biomedicine | Hematology | Science & Technology | Medical research | Care and treatment | Relapse | Dexamethasone | Multiple myeloma | Medicine, Experimental | Diseases | Steroids | Urine | Survival | Patients | Medical prognosis | Index Medicus
Journal Article